SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-001224
Filing Date
2013-03-15
Accepted
2013-03-15 13:51:02
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT sbfm_10k.htm 10-K 1451119
2 CERTIFICATION sbfm_ex311.htm EX-31.1 14370
3 CERTIFICATION sbfm_ex312.htm EX-31.2 14339
4 CERTIFICATION sbfm_ex32.htm EX-32 7112
5 img001.jpg GRAPHIC 38701
6 img002.jpg GRAPHIC 35401
7 img003.jpg GRAPHIC 27840
8 img004.jpg GRAPHIC 39367
  Complete submission text file 0001354488-13-001224.txt   3019082

Data Files

Seq Description Document Type Size
9 sbfm-20121231.xml EX-101.INS 131897
10 sbfm-20121231.xsd EX-101.SCH 33428
11 sbfm-20121231_cal.xml EX-101.CAL 20719
12 sbfm-20121231_def.xml EX-101.DEF 48204
13 sbfm-20121231_lab.xml EX-101.LAB 179053
14 sbfm-20121231_pre.xml EX-101.PRE 96083
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52898 | Film No.: 13693314
SIC: 8742 Services-Management Consulting Services
Office of Trade & Services